eli lilly empower pharmacy

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

Houston Public Media · 1d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

The Public's Radio · 2h

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Time6d

How a New Weight-Loss Pill Could Transform Health

Some of the potential iterations of delivery methods Eli Lilly considered for ... drugs move from manufacturers like Lilly, through large distributors and pharmacy benefit managers who ...

Pharmaceutical Technology8h

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Trending now